CING (STOCKS)
Cingulate Inc. Common Stock
$6.570000
-0.250000 (-3.67%)
Prev close: $6.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shane J. Schaffer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $50.92M
- Employees
- 13
- P/E (TTM)
- -1.29
- P/B (TTM)
- 11.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.35 | $-0.83 | -0.5238 | -63.40% |
|
Jun 2025 (Q2)
|
$-1.09 | $-0.89 | -0.1958 | -21.90% |
|
Mar 2025 (Q1)
|
$-1.04 | $-1.03 | -0.0123 | -1.20% |
|
Dec 2024 (Q4)
|
$-4.02 | $-1.48 | -2.5410 | -171.81% |
Financial Statements
| Nonoperating Income/Loss | -$731.97K |
| Research and Development | $12.10M |
| Operating Income/Loss | -$20.56M |
| Income/Loss From Continuing Operations After Tax | -$21.39M |
| Income/Loss From Continuing Operations Before Tax | -$21.39M |
| Net Income/Loss | -$21.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.77 |
| Diluted Earnings Per Share | -$2.77 |
| Basic Average Shares | 5,084,403 |
| Diluted Average Shares | 5,084,403 |
| Assets | $10.52M |
| Current Assets | $7.43M |
| Noncurrent Assets | $3.09M |
| Fixed Assets | $1.69M |
| Other Non-current Assets | $1.39M |
| Liabilities | $7.05M |
| Current Liabilities | $5.88M |
| Accounts Payable | $866.25K |
| Other Current Liabilities | $5.02M |
| Noncurrent Liabilities | $1.16M |
| Equity | $3.47M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.47M |
| Liabilities And Equity | $10.52M |
| Net Cash Flow From Operating Activities | -$17.73M |
| Net Cash Flow From Operating Activities, Continuing | -$17.73M |
| Net Cash Flow From Investing Activities | -$204.39K |
| Net Cash Flow From Investing Activities, Continuing | -$204.39K |
| Net Cash Flow From Financing Activities | $14.01M |
| Net Cash Flow From Financing Activities, Continuing | $14.01M |
| Net Cash Flow | -$3.92M |
| Net Cash Flow, Continuing | -$3.92M |
| Comprehensive Income/Loss | -$21.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.39M |
| Other Comprehensive Income/Loss | $0.00 |